HURA · TuHURA Biosciences, Inc.

TuHURA Biosciences has secured a significant $50 million revolving credit facility from Parkview Holdings One LLC, an affiliate of its largest stockholder K&V Investment One LLC, providing non-equity based capital to fund operations through anticipated key milestones. The facility's structure allows the company to control timing and amount of draws while preserving flexibility for other capital sources. Key terms include a 12% interest rate, five-year maturity, and security interest in substantially all company assets. In partial consideration, TuHURA granted Parkview a royalty on future IFx-2.0 product sales at a low-to-mid single digit percentage of annual net sales up to $450 million, creating a long-term financial obligation tied to commercial success. The agreement also involves extending warrant exercise periods for existing warrants held by the affiliate and includes a $5 million commitment fee payable in shares subject to stockholder approval. This transaction represents a strategic financing arrangement with an affiliated party that provides near-term liquidity while creating future royalty obligations and warrant extensions.